perugu_vada Posted October 13, 2020 Report Share Posted October 13, 2020 Pfizer Inc will enroll participants as young as 12 in its large, late-stage COVID-19 vaccine trial to understand how it works in a wider age group. Last month, Pfizer scaled up its trial to about 44,000 participants, from up to 30,000, to enroll people as young as 16 and those with chronic, stable HIV, hepatitis C and hepatitis B. The company said on Tuesday it would enroll children in its study based on satisfactory safety data in older adolescents and young adults, but did not specify a timeline. Quote Link to comment Share on other sites More sharing options...
-1.thumb.png.613bdd33b4e8b5f69ac815bf90e62a8b.png)
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.